While the industry has made great strides in cancer research and treatments, minority groups in the U.S. continue to bear a greater burden of cancers compared with others.
Alcohol use disorder is a debilitating disease that impacts millions of people every day, and the stigma that surrounds it prevents people from seeking help.
April marks National Minority Health Month, a time for us to reflect on the work still needed to address and break down existing barriers that keep minority communities from seeking mental health care.
In a recent article for Boston Business Journal, Dr. Kanchan Relwani highlights the importance of patient-focused drug development and how we seek to incorporate the patient voice into all we do.
The Royal Albert Hall announced that it has earned the WELL Health-Safety Rating for Facility Operations and Management through the International WELL Building Institute (IWBI).
Dr. D. Kyle Hogarth, the director of bronchoscopy at the University of Chicago, works in a bustling ICU where he often needs to perform rapid endoscopic procedures.
This remarkable innovation received FDA approval for the treatment of HCC earlier this year. Now, the Boston Scientific team is exploring how TheraSphere might be used to treat other types of tumors.
For 29-year-old Katharina Bauer, pole vaulting is her life’s passion. In April 2018, she was implanted with the Boston Scientific EMBLEMTM MRI S-ICD System.
The SCS Kingfisher certification mark is showing up on an increasing number of products around the world. It differentiates companies that are making...
Corporate governance, risk management, operational integrity, and regulatory compliance are demanding challenges that companies face in today’s ever...
Cascale shares updates on its strategic partnerships with industry stakeholders geared toward shifting the industry into one that gives back more than...
